262 related articles for article (PubMed ID: 29450806)
1. Dissolution and oral bioavailability enhancement of praziquantel by solid dispersions.
Liu Y; Wang T; Ding W; Dong C; Wang X; Chen J; Li Y
Drug Deliv Transl Res; 2018 Jun; 8(3):580-590. PubMed ID: 29450806
[TBL] [Abstract][Full Text] [Related]
2. Structural Elucidation of Poloxamer 237 and Poloxamer 237/Praziquantel Solid Dispersions: Impact of Poly(Vinylpyrrolidone) over Drug Recrystallization and Dissolution.
Orlandi S; Priotti J; Diogo HP; Leonardi D; Salomon CJ; Nunes TG
AAPS PharmSciTech; 2018 Apr; 19(3):1274-1286. PubMed ID: 29313262
[TBL] [Abstract][Full Text] [Related]
3. Albendazole solid dispersions prepared using PEG6000 and Poloxamer188: formulation, characterization and
Dong CL; Zheng SD; Liu YY; Cui WQ; Hao MQ; God'spower BO; Chen XY; Li YH
Pharm Dev Technol; 2020 Nov; 25(9):1043-1052. PubMed ID: 32546042
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of melt granulation and ultrasonic spray congealing as techniques to enhance the dissolution of praziquantel.
Passerini N; Albertini B; Perissutti B; Rodriguez L
Int J Pharm; 2006 Aug; 318(1-2):92-102. PubMed ID: 16697539
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of a novel spot-on formulation of praziquantel for dogs.
Gutiérrez ML; Di Federico G; Dale JA; Minoia JM; Corrales CD; Schaiquevich P; Wikinski S
Vet Parasitol; 2017 May; 239():46-49. PubMed ID: 28495196
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of dissolution and oral bioavailability by adjusting microenvironment pH in crocetin ternary solid dispersions: Optimization, characterization, in vitro evaluation, and pharmacokinetics.
Tong Z; Liu X; Tao Y; Feng P; Luan F; Jie X; Xie Z; Pu F; Xu Z; Wang P
Drug Deliv Transl Res; 2024 Jul; 14(7):1923-1939. PubMed ID: 38117406
[TBL] [Abstract][Full Text] [Related]
7. Microenvironmental pH-modified solid dispersions to enhance the dissolution and bioavailability of poorly water-soluble weakly basic GT0918, a developing anti-prostate cancer drug: preparation, characterization and evaluation in vivo.
Yang M; He S; Fan Y; Wang Y; Ge Z; Shan L; Gong W; Huang X; Tong Y; Gao C
Int J Pharm; 2014 Nov; 475(1-2):97-109. PubMed ID: 25171976
[TBL] [Abstract][Full Text] [Related]
8. Transdermal evaporation delivery system of praziquantel for schistosomiasis japonicum chemotherapy.
Wang L; Zheng X; Fang Y; Wang Y; Duan C; Yao B
J Pharm Sci; 2011 Jul; 100(7):2769-77. PubMed ID: 21319162
[TBL] [Abstract][Full Text] [Related]
9. Praziquantel systems with improved dissolution rate obtained by high pressure homogenization.
Gonzalez MA; Ramírez Rigo MV; Gonzalez Vidal NL
Mater Sci Eng C Mater Biol Appl; 2018 Dec; 93():28-35. PubMed ID: 30274060
[TBL] [Abstract][Full Text] [Related]
10. Bioavailability and in vivo efficacy of a praziquantel-polyvinylpyrrolidone solid dispersion in Schistosoma mansoni-infected mice.
El-Lakkany N; Seif El-Din SH; Heikal L
Eur J Drug Metab Pharmacokinet; 2012 Dec; 37(4):289-99. PubMed ID: 22460595
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of rofecoxib-polyethylene glycol 4000 solid dispersions and tablets based on solid dispersions.
Liu C; Desai KG
Pharm Dev Technol; 2005; 10(4):467-77. PubMed ID: 16370176
[TBL] [Abstract][Full Text] [Related]
12. Unexpected solvent impact in the crystallinity of praziquantel/poly(vinylpyrrolidone) formulations. A solubility, DSC and solid-state NMR study.
Costa ED; Priotti J; Orlandi S; Leonardi D; Lamas MC; Nunes TG; Diogo HP; Salomon CJ; Ferreira MJ
Int J Pharm; 2016 Sep; 511(2):983-93. PubMed ID: 27506511
[TBL] [Abstract][Full Text] [Related]
13. Third-generation solid dispersion combining Soluplus and poloxamer 407 enhances the oral bioavailability of resveratrol.
Vasconcelos T; Prezotti F; Araújo F; Lopes C; Loureiro A; Marques S; Sarmento B
Int J Pharm; 2021 Feb; 595():120245. PubMed ID: 33484925
[TBL] [Abstract][Full Text] [Related]
14. Enhanced dissolution and oral bioavailability of praziquantel by emulsification with human serum albumin followed by spray drying.
Yamasaki K; Taguchi K; Nishi K; Otagiri M; Seo H
Eur J Pharm Sci; 2019 Nov; 139():105064. PubMed ID: 31491499
[TBL] [Abstract][Full Text] [Related]
15. Enhanced dissolution and oral bioavailability of valsartan solid dispersions prepared by a freeze-drying technique using hydrophilic polymers.
Xu WJ; Xie HJ; Cao QR; Shi LL; Cao Y; Zhu XY; Cui JH
Drug Deliv; 2016; 23(1):41-8. PubMed ID: 24735247
[TBL] [Abstract][Full Text] [Related]
16. Relative Bioavailability of Orally Dispersible Tablet Formulations of Levo- and Racemic Praziquantel: Two Phase I Studies.
Bagchus WM; Bezuidenhout D; Harrison-Moench E; Kourany-Lefoll E; Wolna P; Yalkinoglu O
Clin Transl Sci; 2019 Jan; 12(1):66-76. PubMed ID: 30536632
[TBL] [Abstract][Full Text] [Related]
17. Preparation, characterization and tableting of cilnidipine solid dispersions.
Hu L; Song W; Niu F; Jiao K; Jia Z
Pak J Pharm Sci; 2013 May; 26(3):629-36. PubMed ID: 23625441
[TBL] [Abstract][Full Text] [Related]
18. Enhanced dissolution and bioavailability of grapefruit flavonoid Naringenin by solid dispersion utilizing fourth generation carrier.
Khan AW; Kotta S; Ansari SH; Sharma RK; Ali J
Drug Dev Ind Pharm; 2015 May; 41(5):772-9. PubMed ID: 24669978
[TBL] [Abstract][Full Text] [Related]
19. Combining Mechanochemistry and Spray Congealing for New Praziquantel Pediatric Formulations in Schistosomiasis Treatment.
Albertini B; Perissutti B; Bertoni S; Zanolla D; Franceschinis E; Voinovich D; Lombardo F; Keiser J; Passerini N
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30870971
[TBL] [Abstract][Full Text] [Related]
20. Electrosprayed Polymeric Nanospheres for Enhanced Solubility, Dissolution Rate, Oral Bioavailability and Antihyperlipidemic Activity of Bezafibrate.
Sun R; Shen C; Shafique S; Mustapha O; Hussain T; Khan IU; Mehmood Y; Anwer K; Shahzad Y; Yousaf AM
Int J Nanomedicine; 2020; 15():705-715. PubMed ID: 32099359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
